Network pharmacology: curing causal mechanisms instead of treating symptoms

C Nogales, ZM Mamdouh, M List, C Kiel… - Trends in …, 2022 - cell.com
For complex diseases, most drugs are highly ineffective, and the success rate of drug
discovery is in constant decline. While low quality, reproducibility issues, and translational …

Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology

A Petraina, C Nogales, T Krahn, H Mucke… - Cardiovascular …, 2022 - academic.oup.com
Mechanism-based therapy centred on the molecular understanding of disease-causing
pathways in a given patient is still the exception rather than the rule in medicine, even in …

[HTML][HTML] INOCA/ANOCA: Mechanisms and novel treatments

ND Ashokprabhu, O Quesada, YR Alvarez… - American heart journal …, 2023 - Elsevier
Angina or ischemia with no obstructive coronary disease (ANOCA/INOCA) is a common but
under-treated condition due to poorly understood pathophysiologic mechanisms, limited …

A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection

F Langhauser, AI Casas, VTV Dao, E Guney… - NPJ systems biology …, 2018 - nature.com
Network medicine utilizes common genetic origins, markers and co-morbidities to uncover
mechanistic links between diseases. These links can be summarized in the diseasome, a …

cGMP signaling and vascular smooth muscle cell plasticity

M Lehners, H Dobrowinski, S Feil, R Feil - Journal of cardiovascular …, 2018 - mdpi.com
Cyclic GMP regulates multiple cell types and functions of the cardiovascular system. This
review summarizes the effects of cGMP on the growth and survival of vascular smooth …

Visualising and understanding cGMP signals in the cardiovascular system

R Feil, M Lehners, D Stehle… - British Journal of …, 2022 - Wiley Online Library
cGMP is an important signalling molecule in humans. Fluorescent cGMP biosensors have
emerged as powerful tools for the sensitive analysis of cGMP pathways at the single‐cell …

Stimulation of erythrocyte soluble guanylyl cyclase induces cGMP export and cardioprotection in type 2 diabetes

T Jiao, A Collado, A Mahdi, J Tengbom… - Basic to Translational …, 2023 - jacc.org
Reduced nitric oxide (NO) bioactivity in red blood cells (RBCs) is critical for augmented
myocardial ischemia-reperfusion injury in type 2 diabetes. This study identified the nature of …

Endothelial SIRT1 prevents age-induced impairment of vasodilator responses by enhancing the expression and activity of soluble guanylyl cyclase in smooth muscle …

Y Guo, C Xu, AWC Man, B Bai, C Luo… - Cardiovascular …, 2019 - academic.oup.com
Aims Aged arteries are characterized by attenuated vasodilator and enhanced
vasoconstrictor responses, which contribute to the development of diseases such as arterial …

Sanguisorba officinalis L. suppresses non-small cell lung cancer via downregulating the PI3K/AKT/mTOR signaling pathway based on network pharmacology and …

H Li, J Lin, F Yang, J Deng, J Lai, J Zeng… - Frontiers in …, 2022 - frontiersin.org
Background: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer.
Sanguisorba officinalis L.(SOL), a traditional Chinese herbal medicine called Diyu, has been …

GPCRs are optimal regulators of complex biological systems and orchestrate the interface between health and disease

H Leysen, D Walter, B Christiaenssen… - International journal of …, 2021 - mdpi.com
GPCRs arguably represent the most effective current therapeutic targets for a plethora of
diseases. GPCRs also possess a pivotal role in the regulation of the physiological balance …